Enhancer ID: | E_01_0876 |
Species: | human |
Position : | chr2:25730681-25732681 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Colorectal cancer |
Pubmed ID: | 33116876 |
Enhancer experiment: | Quantitative real-time polymerase chain reaction (QRT PCR), Western blot analysis and immunohistochemistry (IHC) |
Enhancer experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
TF name : | ASXL2 |
TF experiment: | ???????????qRT-PCR???????????????IHC? |
TF experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
Enhancer function : | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|